Genome-wide Association Study of Susceptibility Loci for Self-Reported Atopic Dermatitis and Allergic Rhinitis in the Korean Population
Annals of Dermatology · 2024 · 36 (2) · 74
DOI: 10.5021/ad.22.160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Dermatology, 2024. Verfasst von Jee Woo Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, Korea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Seoul National University Bundang Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, Korea. vividna@gmail.com.
ORCID-Profile: Jee Woo Kim, Min Jae Kim, Kyungho Paik, Bo Ri Kim, Chong Won Choi, Jung-Im Na
Förderung
- Seoul National University Bundang Hospital
Zitieren
APA
Kim, J. W., Kim, M. J., Paik, K., Kim, B. R., Choi, C. W., & Na, J. I. (2024). Genome-wide Association Study of Susceptibility Loci for Self-Reported Atopic Dermatitis and Allergic Rhinitis in the Korean Population. Annals of Dermatology, 36(2), 74. https://doi.org/10.5021/ad.22.160
Vancouver
Kim JW, Kim MJ, Paik K, Kim BR, Choi CW, Na JI. Genome-wide Association Study of Susceptibility Loci for Self-Reported Atopic Dermatitis and Allergic Rhinitis in the Korean Population. Annals of Dermatology. 2024;36(2):74. doi:10.5021/ad.22.160
BibTeX
@article{Kim2024,
author = {Kim, Jee Woo and Kim, Min Jae and Paik, Kyungho and Kim, Bo Ri and Choi, Chong Won and Na, Jung-Im},
title = {Genome-wide Association Study of Susceptibility Loci for Self-Reported Atopic Dermatitis and Allergic Rhinitis in the Korean Population},
journal = {Annals of Dermatology},
year = {2024},
volume = {36},
number = {2},
pages = {74},
doi = {10.5021/ad.22.160}
}
EUVIMED